Xinyun Xu

Xinyun Xu


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Toxicology Research
Verified
Journal Article
Open access
PDF file
XQXiaoyun Qin
Xiaoyun Qin
QMQuan Ma
Quan Ma
JYJianhui Yuan
Jianhui Yuan
XHXinnan Hu
Xinnan Hu
QTQin Tan
Qin Tan
XXXinyun Xu
Xinyun Xu
The objective of this study is to determine testicular pathological damage and explore its molecular mechanisms after di-2-ethylhexyl phthalate (DEHP) treatment.

23 April 2020 in Environmental Toxicology and Chemistry
Verified
Journal Article
Closed access
PDF file
SQShuangjian Qin
Shuangjian Qin
BLBoru Li
Boru Li
XWXun Wang
Xun Wang
HHHaiyan Huang
Haiyan Huang
MZMing Zeng
Ming Zeng
XXXinyun Xu
Xinyun Xu

1 May 2021 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
YCYing Cai
Ying Cai
RLRunbing Li
Runbing Li
KZKai Zheng
Kai Zheng
BWBingyu Wang
Bingyu Wang
SQShuangjian Qin
Shuangjian Qin
XXXinyun Xu
Xinyun Xu

1 February 2021 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
SQShuangjian Qin
Shuangjian Qin
BLBoru Li
Boru Li
RLRunbing Li
Runbing Li
YCYing Cai
Ying Cai
KZKai Zheng
Kai Zheng
XXXinyun Xu
Xinyun Xu
Proteomics and bioinformatics were applied to explore PM2.5-induced differentially expressed proteins (DEPs) in hepatocytes (L02 cells) and c-Myc-silenced hepatocytes. L02 cells and c-Myc-silenced hepatocytes were treated with PM2.5 for 24 h. Fifty-two DEPs were screened in L02 hepatocytes, of which 28 were upregulated and 24 were downregulated. Forty-one DEPs were screened in the c-Myc-silenced hepatocytes, of which 31 were upregulated and 10 were downregulated. GO analysis showed that DEPs in L02 cells were mainly concentrated in the cytosol and were involved in biological processes such as the response to metal ions. DEPs in c-Myc-silenced cells were mainly enriched in the extracellular space and were involved in lipoprotein metabolism. KEGG analysis showed that DEPs in L02 cells were mainly involved in arachidonic acid metabolism and mineral absorption. DEPs in c-Myc-silenced cells were mainly enriched in pathways involving nerve absorption, complement and coagulation cascades, and other pathways. Twenty key proteins, including Metallothionein-2A (MT2A), Metallothionein-1X (MT1X), zinc transporter ZIP10 (SLC39A10) and Serine protease 23 (PRSS23) were screened in two groups through analysis of protein-protein interactions. Based on the identification of the selected DEPs, PRSS23 and SLC39A10 might be the potential biomarker of PM2.5-induced carcinogenesis, which provide the scientific basis for further research into the carcinogenic mechanisms of PM2.5.

3 May 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
WDWenjuan Dai
Wenjuan Dai
YFYingbin Fu
Yingbin Fu
YDYanxia Deng
Yanxia Deng
ZZZhuoying Zeng Zhuoying Zeng
Zhuoying Zeng Zhuoying Zeng
PGPan Gu
Pan Gu
HHHaiyan Huang
Haiyan Huang
Benzo(a)pyrene (BaP) is a polycyclic aromatic hydrocarbon that specifically causes cancer and is widely distributed in the environment. Poly (ADP-ribosylation), as a key post-translational modification in BaP-induced carcinogenesis, is mainly catalyzed by poly (ADP-ribose) glycohydrolase (PARG) in eukaryotic organisms. Previously, it is found that PARG silencing can counteract BaP-induced carcinogenesis in vitro, but the mechanism remained unclear. In this study, we further examined this process in vivo by using heterozygous PARG knockout mice (PARG+/−). Wild-type and PARG+/− mice were individually treated with 0 or 10 μg/m3 BaP for 90 or 180 days by dynamic inhalation exposure. Pathological analysis of lung tissues showed that, with extended exposure time, carcinogenesis and injury in the lungs of WT mice was progressively worse; however, the injury was minimal and carcinogenesis was not detected in the lungs of PARG+/− mice. These results indicate that PARG gene silencing protects mice against lung cancer induced by BaP inhalation exposure. Furthermore, as the exposure time was extended, the protein phosphorylation level was down-regulated in WT mice, but up-regulated in PARG+/− mice. The relative expression of Wnt2b and Wnt5b mRNA in WT mice were significantly higher than those in the control group, but there was no significant difference in PARG+/− mice. Meanwhile, the relative expression of Wnt2b and Wnt5b proteins, as assessed by immunohistochemistry and Western blot analysis, was significantly up-regulated by BaP in WT mice; while in PARG+/− mice it was not statistically affected. Our work provides initial evidence that PARG silencing suppresses BaP induced lung cancer and stabilizes the expression of Wnt ligands, PARG gene and Wnt ligands may provide new options for the diagnosis and treatment of lung cancer.

5 December 2014 in Journal of Clinical Bioinformatics
Verified
Journal Article
Open access
JYJian-Feng Yang
Jian-Feng Yang
XDXiaofan DING
Xiaofan DING
LCLei Chen
Lei Chen
WMWai Kin Mat
Wai Kin Mat
MXMichelle Zhi Xu
Michelle Zhi Xu
HXHong Xue
Hong Xue
AluScan combines inter-Alu PCR using multiple Alu-based primers with opposite orientations and next-generation sequencing to capture a huge number of Alu-proximal genomic sequences for investigation. Its requirement of only sub-microgram quantities of DNA facilitates the examination of large numbers of samples. However, the special features of AluScan data rendered difficult the calling of copy number variation (CNV) directly using the calling algorithms designed for whole genome sequencing (WGS) or exome sequencing. In this study, an AluScanCNV package has been assembled for efficient CNV calling from AluScan sequencing data employing a Geary-Hinkley transformation (GHT) of read-depth ratios between either paired test-control samples, or between test samples and a reference template constructed from reference samples, to call the localized CNVs, followed by use of a GISTIC-like algorithm to identify recurrent CNVs and circular binary segmentation (CBS) to reveal large extended CNVs. To evaluate the utility of CNVs called from AluScan data, the AluScans from 23 non-cancer and 38 cancer genomes were analyzed in this study. The glioma samples analyzed yielded the familiar extended copy-number losses on chromosomes 1p and 9. Also, the recurrent somatic CNVs identified from liver cancer samples were similar to those reported for liver cancer WGS with respect to a striking enrichment of copy-number gains in chromosomes 1q and 8q. When localized or recurrent CNV-features capable of distinguishing between liver and non-liver cancer samples were selected by correlation-based machine learning, a highly accurate separation of the liver and non-liver cancer classes was attained. The results obtained from non-cancer and cancerous tissues indicated that the AluScanCNV package can be employed to call localized, recurrent and extended CNVs from AluScan sequences. Moreover, both the localized and recurrent CNVs identified by this method could be subjected to machine-learning selection to yield distinguishing CNV-features that were capable of separating between liver cancers and other types of cancers. Since the method is applicable to any human DNA sample with or without the availability of a paired control, it can also be employed to analyze the constitutional CNVs of individuals.